|
|
drug metabolic process
|
GO:0017144 |
4 |
0.512
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.353
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.336
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.271
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.241
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.241
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.214
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.214
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.202
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.201
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.193
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.186
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.167
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.164
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.159
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.157
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.148
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.137
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.134
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.132
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.132
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.130
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.126
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.118
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.118
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.117
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.116
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.115
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.111
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.100
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.097
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.095
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.095
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.094
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.092
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.092
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.091
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.091
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.091
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.089
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.089
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.088
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.086
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.084
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.084
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.083
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.082
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.081
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.081
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.081
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.079
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.079
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.078
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.077
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.076
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.076
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.076
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.076
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.075
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.074
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.073
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.073
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.070
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.070
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.069
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.068
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.067
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.067
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.066
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.065
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.065
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.064
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.064
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.061
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.061
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.060
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.060
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.060
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.059
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.059
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.058
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.058
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.057
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.057
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.057
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.056
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.056
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.055
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.055
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.055
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.053
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.053
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.052
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.052
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.052
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.051
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.050
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.050
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.050
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.049
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.049
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.049
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.049
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.049
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.048
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.048
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.048
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.048
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.047
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.047
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.047
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.046
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.046
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.046
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.046
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.046
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.046
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.045
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.045
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.045
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.044
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.044
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.044
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.043
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.043
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.042
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.041
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.041
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.040
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.040
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.040
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.040
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.040
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.039
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.039
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.039
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.039
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.038
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.037
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.037
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.037
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.037
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.036
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.036
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.036
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.036
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.035
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.035
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.035
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.035
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.035
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.035
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.035
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.035
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.034
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.034
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.034
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.034
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.034
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.034
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.033
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.033
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.033
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.033
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.033
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.033
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.033
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.032
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.032
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.032
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.032
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.032
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.032
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.031
|
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
16 |
0.031
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.031
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.031
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.031
|
|
|
|
oxygen metabolic process
|
GO:0072592 |
4 |
0.031
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.031
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.031
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.031
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.031
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.030
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.030
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.030
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.030
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.030
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.030
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.030
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.029
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.029
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.029
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.029
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.029
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.029
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.029
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.029
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.029
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.029
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.029
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.029
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.028
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.028
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.028
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.028
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.028
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.028
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.028
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.027
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.027
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.027
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.027
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.027
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.027
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.026
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.026
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.026
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.026
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.026
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.026
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.026
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.026
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.025
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.025
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.025
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.025
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.025
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.025
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.025
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.024
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.024
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.024
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.024
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.024
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.024
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.024
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.024
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.024
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.024
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.024
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.023
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.023
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.023
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.023
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
12 |
0.023
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.023
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.022
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.022
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.022
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.022
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.022
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.022
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.022
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.022
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.022
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.022
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.022
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.022
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.022
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.022
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.022
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.021
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.021
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.021
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.021
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.021
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.021
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.021
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.021
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.020
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.020
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.020
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.020
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.020
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.020
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.020
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.020
|
|
|
|
response to symbiont
|
GO:0009608 |
2 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.020
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.020
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.020
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.020
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.020
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.020
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.020
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.020
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.020
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.020
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.020
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.020
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.020
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.020
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.020
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.020
|
|
|
|
glutathione metabolic process
|
GO:0006749 |
16 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.019
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.019
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.019
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.019
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.019
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.019
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.019
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.019
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.019
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.019
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.018
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.018
|
|
|
|
nadp metabolic process
|
GO:0006739 |
6 |
0.018
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.018
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.018
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.018
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.018
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
chorionic trophoblast cell proliferation
|
GO:0097360 |
1 |
0.018
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.018
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.018
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.018
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.018
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.018
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.018
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.018
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.018
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.018
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.017
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.017
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.017
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.017
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.017
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.017
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.017
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.017
|
|
|
|
nonribosomal peptide biosynthetic process
|
GO:0019184 |
5 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.017
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.017
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.017
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.017
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.017
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.017
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.017
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.017
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.017
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.017
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.016
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.016
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.016
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.016
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.016
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.016
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.016
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.016
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.016
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.016
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.016
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.016
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.016
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.016
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.016
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.016
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.016
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.016
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.016
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.016
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.015
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.015
|
|
|
|
calcium ion dependent exocytosis
|
GO:0017156 |
35 |
0.015
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.015
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.015
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.015
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.015
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.015
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.015
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.015
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.015
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.015
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.015
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.015
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.015
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.015
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.015
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.015
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.015
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.015
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.015
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.015
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.015
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.015
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.015
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.015
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.015
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.015
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.015
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.015
|
|
|
|
negative regulation of macrophage apoptotic process
|
GO:2000110 |
3 |
0.015
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.015
|
|
|
|
myeloid dendritic cell chemotaxis
|
GO:0002408 |
2 |
0.015
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.015
|
|
